1 study on Amyloidogenesis mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study highlights Semax's potential as a therapeutic agent for Alzheimer's disease by directly targeting copper-mediated Abeta toxicity, a key pathway in neurodegeneration. Its ability to interfere with a critical…